Twist Bioscience Corporation (TWST) Operating margin 2017–2025
Twist Bioscience Corporation (TWST) operating margin by fiscal year — reported operating income divided by reported revenue.
-36.2%FY2025 · since FY2017: -543.2% → -36.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -36.2% | +34.4 pp |
| FY2024 | -70.6% | +18.0 pp |
| FY2023 | -88.6% | +26.7 pp |
| FY2022 | -115.3% | +0.1 pp |
| FY2021 | -115.4% | +40.1 pp |
| FY2020 | -155.5% | +44.7 pp |
| FY2019 | -200.1% | +77.3 pp |
| FY2018 | -277.5% | +265.7 pp |
| FY2017 | -543.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TWST financial trends
TWST RevenueTWST Net incomeTWST Net marginTWST Gross profitTWST Gross marginTWST Operating incomeTWST Operating cash flowTWST Free cash flowTWST Capital expendituresTWST Return on equityTWST Stock buybacksTWST Dividends paidTWST Total assetsTWST Total liabilitiesTWST Shareholders’ equityTWST overview →